Investors & Media

Press Releases



All Releases
View Summary TG Therapeutics, Inc. to Present at the 26th Annual ROTH Conference
Mar 10, 2014
PDF 105.8 KB Add to Briefcase
View Summary TG Therapeutics, Inc. Announces Fourth Quarter and Year-End 2013 Financial Results and Business Update
Mar 5, 2014
PDF 118.9 KB Add to Briefcase
View Summary TG Therapeutics, Inc. to Host Conference Call on Fourth Quarter and Year-End 2013 Financial Results and Business Update
Mar 4, 2014
PDF 106.5 KB Add to Briefcase
View Summary TG Therapeutics, Inc. to Present at the 16th Annual BIO CEO & Investor Conference
Feb 7, 2014
PDF 13.8 KB Add to Briefcase
View Summary TG Therapeutics, Inc. to Present at the 32nd Annual J.P. Morgan Healthcare Conference
Jan 13, 2014
PDF 15.4 KB Add to Briefcase
View Summary TG Therapeutics, Inc. Announces Presentation of Encouraging Clinical Activity of TGR-1202 in an Ongoing Multi-Center Phase I Clinical Study
Dec 9, 2013
PDF 114.8 KB Add to Briefcase
View Summary TG Therapeutics, Inc. Launches Combination Clinical Trial of TG-1101 and Ibrutinib in Patients With Select B-Cell Malignancies
Dec 6, 2013
PDF 110.7 KB Add to Briefcase
View Summary TG Therapeutics, Inc. Announces Poster Presentations for TGR-1202 at the Upcoming 55th American Society of Hematology Meeting
Dec 5, 2013
PDF 148.3 KB Add to Briefcase
View Summary TG Therapeutics, Inc. to Present at the 2013 Deutsche Bank BioFEST Conference
Nov 26, 2013
PDF 105.8 KB Add to Briefcase
View Summary TG Therapeutics, Inc. Initiates First Combination Clinical Trial of TG-1101 and TGR-1202 in Patients With Relapsed and/or Refractory CLL and NHL
Nov 25, 2013
PDF 111.0 KB Add to Briefcase
View Summary TG Therapeutics, Inc. Announces Third Quarter 2013 Financial Results and Business Update
Nov 11, 2013
PDF 24.9 KB Add to Briefcase
View Summary TG Therapeutics, Inc. to Host Conference Call on Third Quarter 2013 Financial Results and Business Update
Nov 8, 2013
PDF 106.4 KB Add to Briefcase
View Summary TG Therapeutics, Inc. Comments on Unusual Trading Activity
Oct 28, 2013
PDF 109.6 KB Add to Briefcase
View Summary TG Therapeutics, Inc. to Present at BioCentury's NewsMakers in the Biotech Industry Conference
Sep 25, 2013
PDF 107.5 KB Add to Briefcase
View Summary TG Therapeutics, Inc. Announces Pre-Clinical Poster Presentation for TGR-1202 at the 15th International Workshop on Chronic Lymphocytic Leukemia (iwCLL), Cologne, Germany
Sep 9, 2013
PDF 147.2 KB Add to Briefcase
View Summary TG Therapeutics' Ublituximab (TG-1101) Receives Orphan Drug Designation for the Treatment of Nodal Marginal Zone Lymphoma and Extranodal Marginal Zone Lymphoma (Mucosa-Associated Lymphatic Tissue, MALT)
Sep 9, 2013
PDF 110.2 KB Add to Briefcase
View Summary TG Therapeutics, Inc. Announces Second Quarter 2013 Financial Results and Business Update
Aug 1, 2013
PDF 118.4 KB Add to Briefcase
View Summary TG Therapeutics, Inc. to Host Conference Call on Second Quarter 2013 Financial Results and Business Update
Jul 31, 2013
PDF 107.6 KB Add to Briefcase
View Summary TG Therapeutics, Inc. Announces Exercise of Option to Purchase Additional Shares
Jul 26, 2013
PDF 110.5 KB Add to Briefcase
View Summary TG Therapeutics, Inc. Announces Pricing of Public Offering of Common Stock
Jul 18, 2013
PDF 110.5 KB Add to Briefcase
Showing 161-180 of 214 Page: 1 ... 5 6 7 8 9 10 11  Previous 20 | Next 20
Add to Briefcase = add release to Briefcase